Inventor · disambiguated record
Adrian Tersteegen
Also filed as: SCHAUSS DAGMAR · SCHLEMMER KARL-HEINZ · TERSTEEGEN ADRIAN
42 granted patents·32 pending applications·222 citations·filing 2002–2025
97Inventor score
Top patents by PatentIndex Score
74 records- 0194US11773070B2DihydrooxadiazinonesBAYER AG·Filed 2022·Granted Oct 3, 2023·2 cites·9 claims
- 0294US10300062B2Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2018·Granted May 28, 2019·11 cites·21 claims
- 0393US9949978B2Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2016·Granted Apr 24, 2018·12 cites·42 claims
- 0493US9949977B2Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2016·Granted Apr 24, 2018·12 cites·19 claims
- 0593US9481672B2Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2013·Granted Nov 1, 2016·18 cites·44 claims
- 0693US9023849B2Substituted fused imidazoles and pyrazoles and use thereofBAYER IP GMBH·Filed 2013·Granted May 5, 2015·26 cites·7 claims
- 0793US8859569B2Substituted annellated pyrimidines and use thereofFOLLMANN MARKUS·Filed 2012·Granted Oct 14, 2014·25 cites·8 claims
- 0890US12258323B2DihydrooxadiazinonesBAYER AG·Filed 2022·Granted Mar 25, 2025·1 cites·15 claims
- 0990US11427553B2DihydrooxadiazinonesBAYER AG·Filed 2018·Granted Aug 30, 2022·4 cites·11 claims
- 1089US9822102B2Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disordersBayer Pharma AG·Filed 2016·Granted Nov 21, 2017·7 cites·7 claims
- 1188US9434690B2Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disordersBayer Pharma AG·Filed 2014·Granted Sep 6, 2016·10 cites·8 claims
- 1287US10183932B2Substituted oxopyridine derivatives and use thereof cardiovascular disordersBayer Pharma AG·Filed 2017·Granted Jan 22, 2019·5 cites·8 claims
- 1386US10077265B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2015·Granted Sep 18, 2018·4 cites·14 claims
- 1485US10421742B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2016·Granted Sep 24, 2019·3 cites·9 claims
- 1585US7202243B2Substituted imidazotriazinesBAYER HEALTHCARE AG·Filed 2003·Granted Apr 10, 2007·20 cites·8 claims
- 1684US9475809B2Substituted oxopyridine derivatives and use thereof as factor xia/plasmaBayer Pharma AG·Filed 2014·Granted Oct 25, 2016·6 cites·7 claims
- 1784US9434731B2Imidazo-, pyrazolopyrazines and imidazotriazines and their useBAYER IP GMBH·Filed 2013·Granted Sep 6, 2016·8 cites·3 claims
- 1882US10071995B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2015·Granted Sep 11, 2018·3 cites·15 claims
- 1982US9266871B2Trifluoromethyl-substituted fused pyrimidines and their useBayer Pharma AG·Filed 2014·Granted Feb 23, 2016·5 cites·17 claims
- 2081US10138236B2Factor xia-inhibiting pyridobenzazepine and pyridobenzazocine derivativesBayer Pharma AG·Filed 2015·Granted Nov 27, 2018·4 cites·15 claims
- 2180US6936609B2Imidazotriazines for use as phosphodiesterase inhibitorsBAYER HEALTHCARE AG·Filed 2002·Granted Aug 30, 2005·17 cites·7 claims
- 2279US9765070B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2014·Granted Sep 19, 2017·4 cites·9 claims
- 2378US10167280B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2015·Granted Jan 1, 2019·2 cites·16 claims
- 2478US9918969B2Substituted oxopyridine derivatives and use thereof as factor XIa/plasmaBayer Pharma AG·Filed 2016·Granted Mar 20, 2018·2 cites·3 claims
- 2577US9605008B2Benzyl-1H-pyrazolo[3,4-b]pyridines and use thereofBayer Pharma AG·Filed 2014·Granted Mar 28, 2017·3 cites·24 claims
- 2677US2025282748A1Substituted oxopyridine derivativesBayer Pharma AG·Filed 2025·Application pending·0 cites
- 2774US11912692B2Substituted S-alaninate derivativesBAYER AG·Filed 2023·Granted Feb 27, 2024·0 cites·17 claims
- 2874US9751843B2Substituted uracils and use thereofBayer Pharma AG·Filed 2014·Granted Sep 5, 2017·2 cites·10 claims
- 2974US2024182452A16-phenyl-4,5-dihydropyridazin-3(2h)-one derivatives as pde3a and pde3b inhibitors for treating cancerBAYER AG·Filed 2023·Application pending·0 cites
- 3073US10414731B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2015·Granted Sep 17, 2019·1 cites·6 claims
- 3171US12503491B2MASP inhibitory compounds and uses thereofBAYER AG·Filed 2023·Granted Dec 23, 2025·0 cites·8 claims
- 3271US9505786B2Substituted annulated triazines and use thereofBAYER IP GMBH·Filed 2015·Granted Nov 29, 2016·1 cites·6 claims
- 3371US8383822B2Substituted oxazolidinones and their useBAYER IP GMBH·Filed 2008·Granted Feb 26, 2013·1 cites·11 claims
- 3471US2023024752A1Substituted oxopyridine derivativesBayer Pharma AG·Filed 2021·Application pending·0 cites
- 3570US8436003B2Substituted imidazo- and triazolopyrimidines, imidazo- and pyrazolopyrazines and imidazotriazinesSIEGEL STEPHAN·Filed 2009·Granted May 7, 2013·1 cites·7 claims
- 3668US8664246B2Substituted pyridines, and use thereof as GSK3 inhibitorsSIEGEL STEPHAN·Filed 2009·Granted Mar 4, 2014·1 cites·8 claims
- 3767US11180471B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2019·Granted Nov 23, 2021·0 cites·67 claims
- 3865US12427153B21,2,4-triazin-3(2H)-one compounds for the treatment of hyperproliferative diseasesBAYER AG·Filed 2021·Granted Sep 30, 2025·0 cites·8 claims
- 3965US9688699B23-(pyrimidine-2-yl)imidazo[1,2-a]pyridinesBayer Pharma AG·Filed 2015·Granted Jun 27, 2017·1 cites·11 claims
- 4065US2020061063A1Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2019·Application pending·0 cites
- 4163US2025002483A1Substituted s-alaninate derivativesBAYER AG·Filed 2022·Application pending·0 cites
- 4262US11667675B2MASP inhibitory compounds and uses thereofBAYER AG·Filed 2020·Granted Jun 6, 2023·0 cites·3 claims
- 4360US11884660B2Substituted oxopyridine derivativeBayer Pharma AG·Filed 2019·Granted Jan 30, 2024·0 cites·7 claims
- 4460US2025170136A11,2,4-triazin-3(2h)-one compounds for the treatment of hyperproliferative diseasesBAYER AG·Filed 2025·Application pending·0 cites
- 4559US2025302837A1Inhibitors of chymase for use in the selective resolution of thrombi in thrombotic or thromboembolic disordersSOCPRA SCIENCES SANTE ET HUMAINES S E C·Filed 2023·Application pending·0 cites
- 4655US8476267B2Imidazo-, pyrazolopyrazines and imidazotriazines and their useSIEGEL STEPHAN·Filed 2008·Granted Jul 2, 2013·0 cites·7 claims
- 4754US2015105374A1Substituted annellated pyrimidines and use thereofBAYER IP GMBH·Filed 2014·Application pending·0 cites
- 4852US2024010684A1Masp inhibitory compounds and uses thereofBAYER AG·Filed 2021·Application pending·0 cites
- 4950US2014357637A1Substituted annulated pyrimidines and triazines, and use thereofBAYER INTELLECTUAL PROPERTIES GMBH·Filed 2013·Application pending·0 cites
- 5049US8846934B2Substituted oxazolidinones and their useBAYER IP GMBH·Filed 2013·Granted Sep 30, 2014·0 cites·9 claims
Showing the top 50 of 74 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Adrian Tersteegen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →